Severe Hypocalcemia and Hypomagnesemia with Denosumab in Advanced Chronic Kidney Disease: Case Report and Literature Review

about

Severe Hypocalcemia and Hypomagnesemia with Denosumab in Advanced Chronic Kidney Disease: Case Report and Literature Review

Item

http://www.wikidata.org/entity/Q58567262

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Severe Hypocalcemia and Hypoma ...... e Report and Literature Review

@en

Severe Hypocalcemia and Hypoma ...... e Report and Literature Review

@nl

type

Item

label

Severe Hypocalcemia and Hypoma ...... e Report and Literature Review

@en

Severe Hypocalcemia and Hypoma ...... e Report and Literature Review

@nl

prefLabel

Severe Hypocalcemia and Hypoma ...... e Report and Literature Review

@en

Severe Hypocalcemia and Hypoma ...... e Report and Literature Review

@nl

P1476

Severe Hypocalcemia and Hypoma ...... e Report and Literature Review

@en

P2093

Faizan Babar

http://www.w3.org/2001/XMLSchema#string

Shailendra Sharma

http://www.w3.org/2001/XMLSchema#string

P2860

Hypomagnesemia.

Toxicities following treatment with bisphosphonates and receptor activator of nuclear factor-κB ligand inhibitors in patients with advanced prostate cancer.

High bone turnover elevates the risk of denosumab-induced hypocalcemia in women with postmenopausal osteoporosis.

Clinical pharmacokinetics of therapeutic monoclonal antibodies.

Tolerability of denosumab in metastatic solid tumor patients with renal insufficiency.

OPG/membranous--RANKL complex is internalized via the clathrin pathway before a lysosomal and a proteasomal degradation.

Denosumab-associated hypocalcaemia: incidence, severity and patient characteristics in a tertiary hospital setting.

Hypocalcaemia in patients with metastatic bone disease treated with denosumab.

Severe Hypocalcemia Associated With Denosumab in Metastatic Castration-Resistant Prostate Cancer: Risk Factors and Precautions for Treating Physicians.

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study.

P304

2059364

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1155/2018/2059364

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

Christina F Marlow

Jianqing Lin

P577

2018-10-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30405927

http://www.w3.org/2001/XMLSchema#string

P932

6204163

http://www.w3.org/2001/XMLSchema#string